- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about NVTA
Recent news which mentions NVTA
10 Health Care Stocks Whale Activity In Today's Session
March 18, 2022
From Benzinga
From Motley Fool
Invitae Shares Fall As Q4 Earnings Fall Short Of Street Expectation
February 25, 2022
Tickers
NVTA
From Benzinga
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
February 24, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
February 23, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
From Benzinga
From Motley Fool
From Motley Fool
Stocks That Hit 52-Week Lows On Wednesday
January 05, 2022
From Benzinga
63 Biggest Movers From Friday
December 20, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
December 10, 2021
From Benzinga
3 Stocks to Buy From Catastrophic Price Action
November 18, 2021
From InvestorPlace
3 Beaten-Down Genomics Stocks: Can They Recover?
November 16, 2021
From Motley Fool
4 stock picks for the post-pandemic ‘nesting’ economy from a five-star money manager
November 15, 2021
From MarketWatch
75 Biggest Movers From Yesterday
November 10, 2021
From Benzinga
58 Stocks Moving In Monday's Mid-Day Session
November 09, 2021
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 09, 2021
From Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
From Benzinga
32 Stocks Moving in Tuesday's Pre-Market Session
November 09, 2021
From Benzinga
From InvestorPlace
3 Stocks That Could Soar 46% or More, According to Wall Street
November 09, 2021
From Motley Fool
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
From Benzinga
Earnings Scheduled For November 8, 2021
November 08, 2021
From Benzinga
3 Cathie Wood Stocks to Watch This Earnings Season
October 26, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.